⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for KRT-232 in Subjects With Relapsed or Refractory Small Cell Lung Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: KRT-232 in Subjects With Relapsed or Refractory Small Cell Lung Cancer

Official Title: An Open-Label, Multicenter, Phase 2 Study of the Safety and Efficacy of KRT-232 in Subjects With Relapsed or Refractory Small Cell Lung Cancer (SCLC)

Study ID: NCT05027867

Interventions

KRT-232

Study Description

Brief Summary: This study evaluates KRT-232, a novel oral small molecule inhibitor of MDM2, for the treatment of patients with relapsed or refractory small cell lung cancer. This study will be conducted in 2 parts. Part 1 will evaluate two treatment arms, each with a different KRT-232 dose. Part 2 will continue the evaluation of the selected treatment arms from Part 1.

Detailed Description:

Keywords

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Florida Cancer Specialists - 3840 Broadway, Fort Myers, Florida, United States

Florida Cancer Specialists - 560 Jackson St, Suite 220, Saint Petersburg, Florida, United States

Florida Cancer Specialists, West Palm Beach, Florida, United States

Northwest Georgia Oncology Centers, Marietta, Georgia, United States

Hematology Oncology Clinic, Baton Rouge, Louisiana, United States

University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States

Mark H Zangmeister Center - 3100 Plaza Properties Boulevard, Columbus, Ohio, United States

SCRI Tennessee Oncology Chattanooga, Chattanooga, Tennessee, United States

SCRI Tennessee Oncology Nashville, Nashville, Tennessee, United States

Flinders Medical Centre, Bedford Park, South Australia, Australia

Centre Hospitalier de Mulhouse - Hopital Emile Muller, Mulhouse, France/Haut-Rhin, France

Edog - Ico - Ppds, Angers, Maine-et-Loire, France

Hôpital Louis Pradel, Bron, Rhône, France

Hospices Civils de Lyon, Lyon, Rhône, France

Hôpital de La Croix Rousse, Pierre-Bénite, Rhône, France

EDOG - Institut Bergonie - PPDS, Bordeaux, , France

CHU de Grenoble, Grenoble, , France

Hopital Nord AP-HM, Marseille, , France

Klinik für Kardiologie, Angiologie und Pneumologie, Esslingen am Neckar, Baden-Württemberg, Germany

Lungenfachklinik Immenhausen, Immenhausen, Hessen, Germany

Evangelische Lungenklinik Berlin, Berlin, , Germany

Bacs Kiskun Megyei Korhaz, Kecskemét, Bács-Kiskun, Hungary

Chungbuk National University Hospital, Cheongju-si, Chungcheongbuk-do, Korea, Republic of

CHA Bundang Medical Center, CHA University, Seongnam-si, Gyeonggido, Korea, Republic of

Clinica Universidad Navarra, Pamplona, Navarra, Spain

Hospital Universitario 12 de Octubre, Alicante, , Spain

Hospital General Universitario de Alicante, Alicante, , Spain

Hospital Universitario Vall d'Hebrón - PPDS, Barcelona, , Spain

Clinica Universidad Navarra - Madrid, Madrid, , Spain

Hospital Universitario La Paz, Madrid, , Spain

Hospital Regional Universitario de Malaga - Hospital Civil, Málaga, , Spain

Hospital Universitario Virgen Macarena, Sevilla, , Spain

Hospital Universitari i Politecnic La Fe de Valencia, Valencia, , Spain

Contact Details

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: